Annual Total Liabilities
$14.73 M
+$2.95 M+25.06%
31 March 2022
Summary:
Sio Gene Therapies annual total liabilities is currently $14.73 million, with the most recent change of +$2.95 million (+25.06%) on 31 March 2022. During the last 3 years, it has risen by +$2.95 million (+25.06%).SIOX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.15 M
-$2.68 M-55.48%
31 December 2022
Summary:
Sio Gene Therapies quarterly total liabilities is currently $2.15 million, with the most recent change of -$2.68 million (-55.48%) on 31 December 2022.SIOX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | +25.1% | -87.4% |
5 y5 years | -77.8% | -94.2% |
SIOX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -84.9% | -97.9% |
Sio Gene Therapies Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | - | $2.15 M(-55.5%) |
Sept 2022 | - | $4.83 M(-54.8%) |
June 2022 | - | $10.70 M(-27.3%) |
Mar 2022 | $14.73 M(+25.1%) | $14.73 M(-13.5%) |
Dec 2021 | - | $17.04 M(+52.5%) |
Sept 2021 | - | $11.17 M(+31.2%) |
June 2021 | - | $8.52 M(-27.7%) |
Mar 2021 | $11.78 M(-63.3%) | $11.78 M(+18.6%) |
Dec 2020 | - | $9.94 M(-1.6%) |
Sept 2020 | - | $10.10 M(-18.9%) |
June 2020 | - | $12.46 M(-61.2%) |
Mar 2020 | $32.12 M(-51.7%) | $32.12 M(-13.7%) |
Dec 2019 | - | $37.22 M(-36.9%) |
Sept 2019 | - | $59.02 M(-18.1%) |
June 2019 | - | $72.09 M(+8.4%) |
Mar 2019 | $66.49 M | $66.49 M(-9.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | - | $73.46 M(-10.8%) |
Sept 2018 | - | $82.31 M(+0.7%) |
June 2018 | - | $81.76 M(-8.7%) |
Mar 2018 | $89.50 M(-8.4%) | $89.50 M(-0.2%) |
Dec 2017 | - | $89.72 M(-3.5%) |
Sept 2017 | - | $92.96 M(-9.6%) |
June 2017 | - | $102.81 M(+5.2%) |
Mar 2017 | $97.70 M(+520.1%) | $97.70 M(+146.8%) |
Dec 2016 | - | $39.59 M(+38.2%) |
Sept 2016 | - | $28.64 M(+69.2%) |
June 2016 | - | $16.93 M(+7.5%) |
Mar 2016 | $15.76 M(+77.7%) | $15.76 M(-0.9%) |
Dec 2015 | - | $15.89 M(+53.1%) |
Sept 2015 | - | $10.38 M(+8.5%) |
June 2015 | - | $9.57 M |
Mar 2015 | $8.87 M | - |
FAQ
- What is Sio Gene Therapies annual total liabilities?
- What is the all time high annual total liabilities for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sio Gene Therapies?
What is Sio Gene Therapies annual total liabilities?
The current annual total liabilities of SIOX is $14.73 M
What is the all time high annual total liabilities for Sio Gene Therapies?
Sio Gene Therapies all-time high annual total liabilities is $97.70 M
What is Sio Gene Therapies quarterly total liabilities?
The current quarterly total liabilities of SIOX is $2.15 M
What is the all time high quarterly total liabilities for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly total liabilities is $102.81 M